Title: Differences in Antibody Responses of Intradermal and Intramuscular Injections of Botulinum Toxin Type A Authors: Yuttana Srinoulprasert, et al. Published: Dermatol Ther (Heidelb), September 2025 Keywords: Botulinum toxin type
Dr Harry James explores the anatomical principles as well as the clinical technique and patient selection criteria relevant to lip flip procedures The lip flip is a minimally-invasive technique of
Dr Souphiyeh Samizadeh explores the ageing of the neck and its treatment using botulinum toxin
Global pharmaceutical company Galderma has received top-line results for its phase 2 study in the US on the efficacy and safety of a single dose of abobotulinumtoxinA versus placebo for the treatment of moderate to severe glabellar lines.
A new study published in Plastic and Reconstructive Surgery has suggested that intradermal botulinum toxin injection, or microbotulinum, is a safe and effective method to treat skin flaws.
According to a report published by Fortune Business Insights, the botulinum toxin market will reach US $8,309 million by 2026, exhibiting a compound annual growth rate of 8%.
Aesthetics reports on today’s update from Parliament
Global pharmaceutical company Galderma’s liquid formulation of botulinum toxin type A has achieved positive results for the treatment of glabellar lines in a phase 2 clinical trial.
A pilot study of 18 male patients has demonstrated an increase in hair density and thickness following botulinum toxin treatment.
